Who are Avalo Therapeutics, Inc.'s main suppliers?

Avalo Therapeutics, Inc. (AVTX) key suppliers include: Alto Neuroscience, Inc.. View the full supplier network at chainsifter.com/chain/AVTX.

Who are Avalo Therapeutics, Inc.'s major customers?

Avalo Therapeutics, Inc. (AVTX) key customers include: APOLLO, Alto Neuroscience, Inc., Johnson & Johnson, Johnson & Johnson. View the full customer network at chainsifter.com/chain/AVTX.

What sector is Avalo Therapeutics, Inc. in?

Avalo Therapeutics, Inc. (AVTX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Avalo Therapeutics, Inc. (AVTX): 8 Verified Supply Chain Relationships

1Suppliers

4Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Avalo Therapeutics, Inc. (AVTX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships

2Distinct source URLs

5High confidence

0.820Average confidence

2026-10-29Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Avalo Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
ANRO	Alto Neuroscience, Inc.	72%	Reciprocal relationship from ANRO graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from ANRO graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from ANRO g…

Avalo Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
APOLLO	APOLLO	90%	In the event that J&J and/or Apollo are required to make payment(s) to ES Therapeutics pursuant to the underlying agreements, Avalo will recognize revenue under its existing contracts with those cust…
ANRO	Alto Neuroscience, Inc.	72%	Reciprocal relationship from ANRO graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from ANRO graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from ANRO g…
JNJ	Johnson & Johnson	72%	rch 23, 2026, except for the policies as described below. Recently Issued Accounting Pronouncements Not Yet Adopted In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narro…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from AVTX graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AVTX graph: rch 23, 2026, except for the policies…

Avalo Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
AVTX-DEBT-8001	Warrants outstanding: 4000000	90%	xbrl warrant detail from xbrl 2025-12-31.
AVTX-DEBT	Debt stack $15.3M	90%	Market cache reports total debt of $15.3M.
AVTX-DEBT-8002	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Avalo Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Avalo Therapeutics, Inc..

Avalo Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
AVTX-OWNER-FMR-LLC	FMR LLC	90%	13F overlay lists FMR LLC as top holder; 101 tracked holders.

Avalo Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ACIU	AC Immune SA	100.00	2
ATON	AlphaTON Capital Corp	100.00	2
CLGN	CollPlant Biotechnologies Ltd.	100.00	2
ABBV	AbbVie Inc.	100.00	2
AURA	Aura Biosciences, Inc.	100.00	2
AORT	Artivion, Inc.	100.00	2
BLLN	BillionToOne, Inc.	100.00	2
ATRA	Atara Biotherapeutics, Inc.	100.00	2
BCAX	Bicara Therapeutics Inc.	100.00	2
ADGM	Adagio Medical Holdings, Inc.	100.00	2
ANRO	Alto Neuroscience, Inc.	100.00	1	['customer', 'supplier']
ANIK	Anika Therapeutics, Inc.	100.00	2
BNR	Burning Rock Biotech Limited	100.00	2
BNRG	Brenmiller Energy Ltd	100.00	2
CSTE	Caesarstone Ltd.	100.00	2
AVBP	ArriVent BioPharma, Inc.	100.00	2
CYTOF	Altamira Therapeutics Ltd.	100.00	2
SNNUF	Smith & Nephew plc	100.00	2
ALC	Alcon Inc.	100.00	2
FDMT	4D Molecular Therapeutics, Inc.	100.00	2

Avalo Therapeutics, Inc. Supply Chain